tiprankstipranks
Salarius Pharmaceuticals Inc (SLRX)
NASDAQ:SLRX
Holding SLRX?
Track your performance easily

Salarius Pharmaceuticals (SLRX) Financial Statements

494 Followers

Salarius Pharmaceuticals Financial Overview

Salarius Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-8.193; its P/E ratio is -0.17; Salarius Pharmaceuticals is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -972.12K$ -1.42M$ -1.72M$ -970.70K$ -2.53M
EBITDA$ -971.02K$ -1.42M$ -1.71M$ -969.60K$ -2.53M
Net Income Common Stockholders$ -972.12K$ -1.42M$ -1.72M$ -881.81K$ -2.44M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.28M$ 3.27M$ 4.37M$ 5.90M$ 7.58M
Total Assets$ 3.86M$ 3.55M$ 4.88M$ 6.59M$ 8.40M
Total Debt$ 300.00K$ 0.00$ 100.00K$ 300.00K$ 500.00K
Net Debt$ -2.98M$ -3.27M$ -4.27M$ -5.60M$ -7.08M
Total Liabilities$ 934.58K$ 1.18M$ 1.23M$ 1.30M$ 2.32M
Stockholders Equity$ 2.92M$ 2.38M$ 3.65M$ 5.29M$ 6.08M
Cash Flow-
Free Cash Flow$ -1.36M$ -1.07M$ -1.35M$ -1.51M$ -3.75M
Operating Cash Flow$ -1.36M$ -1.07M$ -1.35M$ -1.51M$ -3.75M
Investing Cash Flow-----
Financing Cash Flow$ 1.37M$ -28.19K$ -172.75K$ -169.45K$ -211.83K
Currency in USD

Salarius Pharmaceuticals Earnings and Revenue History

Salarius Pharmaceuticals Debt to Assets

Salarius Pharmaceuticals Cash Flow

Salarius Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis